Trial Details

COMPLETED
Basic Information
Clinical ID c1085
Identifier NCT06281704
Trial Title A Study of AK101 in Subjects With Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions BIOLOGICAL: AK101 IV|BIOLOGICAL: AK101 SC|BIOLOGICAL: Placebo|BIOLOGICAL: AK101 IV/AK101 SC
Participant Information
Sponsor Akeso
City Bengbu
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2020-11-26
Primary Completion Date 2022-05-17
Completion Date 2022-12-31